Ropes & Gray Wins Mergers & Acquisitions Mid-Market Deals of the Year for Advising Audax Private Equity

In The News
May 16, 2024

Ropes & Gray represented Audax Private Equity in the sale of CorEvitas, LLC to Thermo Fisher Scientific Inc., which has been named a 2024 Mid-Market Deal of the Year by Mergers & Acquisitions. The deal team was led by private equity partner Ken Chow, finance partner Mike Lee, employment partner Megan Bisk, executive compensation & employee benefits partner Jenny Rikoski, litigation & enforcement partners Samer Musallam and Thomas Brown, healthcare partner Michael Lampert, and environmental partner Peter Alpert.

“These exceptional transactions transcended a variety of market headwinds faced by dealmakers in the last year,” Mergers & Acquisitions wrote of the 2024 mid-market deals that received recognition.

CorEvitas is a provider of regulatory-grade, real world evidence for approved medical treatments and therapies. Based in Boston and San Francisco, Audax Private Equity is a leading middle market investment firm with approximately $16 billion of assets under management.